文献速递神经肿瘤脊柱脊髓外科

立体定向体部放疗用于转移性硬膜外脊髓压迫术后再照射

Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression.
PubMed 文献 · J Neurosurg Spine · 2018-06-15

回顾性分析28例既往接受过放疗的转移性硬膜外脊髓压迫患者,在减压手术后行脊柱立体定向体部放疗再照射(24 Gy分2次),1年局部控制率为70%,Rades预后评分有利组1年局部控制率显著高于不利组(100% vs 33%,p < 0.01)。

要点

  • 术后脊柱SBRT再照射的1年局部控制率为70%。
  • Rades评分有利组1年局部控制率100% vs 不利组33%(p < 0.01)。
  • 放射性脊髓病1例,椎体压缩性骨折3例,未见其他3级及以上毒性。

核心结论

  • 脊柱SBRT作为术后再照射是有效的,尤其对按Rades评分判定为生存预后良好的患者有用。

研究设计与样本

  • 回顾性 review,纳入2013年4月至2017年5月期间既往接受过放疗的转移性硬膜外脊髓压迫患者,行减压手术后再行脊柱SBRT再照射,共28例。
  • 手术主要采用后路入路,包括减压和固定。
  • 脊柱SBRT处方剂量为24 Gy分2次。
  • 主要结局为局部控制,定义为SBRT后约每3个月CT或MRI上肿瘤消失、缩小或无变化。

主要发现

  • 原发疾病组织学为甲状腺癌7例、肺癌6例、肾癌3例、结直肠癌3例、其他癌症9例。
  • 既往放疗剂量最常见为30 Gy分10次(15例)。
  • 距最近一次放疗的平均间隔为16个月(范围5-132个月)。
  • SBRT后中位随访时间为13个月(范围4-38个月)。
  • 1年局部控制率为70%;Bilsky分级、治疗靶区椎体节段数、最近放疗与SBRT间隔、RPA、PRISM及修订Tokuhashi评分与局部控制无显著相关。

临床怎么用

  • 作者认为脊柱SBRT作为术后再照射有效,尤其对按Rades评分判定为生存预后良好的患者有用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE This study aimed to clarify the outcomes of postoperative re-irradiation using stereotactic body radiotherapy (SBRT) for metastatic epidural spinal cord compression (MESCC) in the authors' institution and to identify factors correlated with local control. METHODS Cases in which patients with previously irradiated MESCC underwent decompression surgery followed by spine SBRT as re-irradiation between April 2013 and May 2017 were retrospectively reviewed. The surgical procedures were mainly performed by the posterior approach and included decompression and fixation. The prescribed dose for spine SBRT was 24 Gy in 2 fractions. The primary outcome was local control, which was defined as elimination, shrinkage, or no change of the tumor on CT or MRI obtained approximately every 3 months after SBRT. In addition, various patient-, treatment-, and tumor-specific factors were evaluated to determine their predictive value for local control. RESULTS Twenty-eight cases were identified in the authors' institutional databases as meeting the inclusion criteria. The histology of the primary disease was thyroid cancer in 7 cases, lung cancer in 6, renal cancer in 3, colorectal cancer in 3, and other cancers in 9. The most common previous radiation dose was 30 Gy in 10 fractions (15 cases). The mean interval since the most recent irradiation was 16 months (range 5-132 months). The median duration of follow-up after SBRT was 13 months (range 4-38 months). The 1-year local control rate was 70%. In the analysis of factors related to local control, Bilsky grade, number of vertebral levels in the treatment target, the interval between the latest radiotherapy and SBRT, recursive partitioning analysis (RPA), the prognostic index for spinal metastases (PRISM), and the revised Tokuhashi score were not significantly correlated with local control. The favorable group classified by the Rades prognostic score achieved a significantly higher 1-year local control rate than the unfavorable group (1-year local control rate: 100% vs 33%; p < 0.01). Radiation-induced myelopathy and vertebral compression fracture were observed in 1 and 3 patients, respectively. No other grade 3 or greater toxicities were encountered. CONCLUSIONS The results indicate that spine SBRT as postoperative re-irradiation was effective, and it was especially useful for patients classified as having a good survival prognosis according to the Rades score.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Ito K, Nihei K, Shimizuguchi T, et al. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression. J Neurosurg Spine. 2018. PMID: 29905524. doi:10.3171/2018.1.SPINE171155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。